The unique properties of ferrocene-containing compounds make them useful for treating many diseases. The most notable drug candidates — the antimalarial ferroquine and the anticancer agent ferrocifen — have been studied for more than two decades but have not yet met clinical approval. This Review describes the design of ferrocene-containing drugs as well as the challenges faced in bringing them into clinical use.
